Byers, K. F. (2021). Ribociclib and Abemaciclib: CDK4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Metastatic Breast Cancer. J Adv Pract Oncol.
シカゴスタイル引用形Byers, Kristina F. "Ribociclib and Abemaciclib: CDK4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Metastatic Breast Cancer." J Adv Pract Oncol 2021.
MLA引用形式Byers, Kristina F. "Ribociclib and Abemaciclib: CDK4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Metastatic Breast Cancer." J Adv Pract Oncol 2021.
警告: この引用は必ずしも正確ではありません.